Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02965651 · ClinicalTrials.gov registry record · NA

Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study

A NA study of Stress, Emotional, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT02965651 is a NA study of Stress, Emotional that has completed, run by Boston Medical Center. The registered enrollment target is 61 participants, below the 373-participant average among 7 other Stress, Emotional trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02965651, a NA study of Stress, Emotional, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled trial is to evaluate the feasibility of introducing an innovative eHealth technology, the Embodied Conversational Agent (ECA), to diverse women from an urban outpatient setting.

Conditions Studied

Interventions

  • BEHAVIORAL ECA System

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2015-01
Est. Completion 2016-01
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT02965651

The ClinicalTrials.gov registry entry for NCT02965651 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 373-participant average among 7 other Stress, Emotional trials with a reported enrollment target (84% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress, Emotional appearing as the primary indexed condition, and to 1 intervention - of which ECA System is the first listed.

NCT02965651 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02965651 about?

NCT02965651 is a clinical study titled "Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study". The purpose of this randomized controlled trial is to evaluate the feasibility of introducing an innovative eHealth technology, the Embodied Conversational Agent (ECA), to diverse women from an urban outpatient setting.

What is the current status of trial NCT02965651?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2015-01. Estimated completion is 2016-01.

What conditions does trial NCT02965651 study?

This clinical trial studies the following conditions: Stress, Emotional.

What interventions are being tested in trial NCT02965651?

The interventions under investigation include: ECA System (BEHAVIORAL).

Who is sponsoring clinical trial NCT02965651?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02965651 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress, Emotional

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.